This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| British American Tobacco | Investec cuts TP to 3750p from 3800p, Buy |
| Catlin Group | UBS initiates with neutral; TP 475p |
| GlaxoSmithKline | UBS ups TP to 1745p from 1450p, neutral |
| Hikma Pharmaceuticals | Goldman Sachs initiates with Buy; TP 1170p |
| Imperial Tobacco Group | Investec ups TP to 2430p from 2370p, Hold |
| Majestic Wine | Investec ups TP to 495p from 480p, Buy |
| Ophir Energy | UBS cuts TP to 500p from 550p, Buy |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research